Prevalence and associated factors of sarcopenia in stroke inpatients: a cross-sectional study with SarQoL-assessed quality of life Authors: Huan Tang, Juan Li, Junrong Chen, Xiaoli Zhu, Mingqing Hao, Lihua Chen, Jian Yang, Chao Xue Published: 2026 ABSTRACT BackgroundStroke is associated with a high burden of sarcopenia, which may be related to poorer functional outcomes and quality of life (QoL).AimTo estimate the prevalence of sarcopenia among stroke inpatients, identify factors associated with stroke-related sarcopenia, and examine the association between stroke-related sarcopenia and sarcopenia-specific QoL.MethodsSarcopenia was evaluated according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria. Demographic and clinical data were collected. Nutritional status, dysphagia, activities of daily living (ADLs), and stroke severity were assessed using the Nutritional Risk Screening 2002 (NRS-2002), Water Swallow Test (WST), Barthel Index (BI), and National Institutes of Health Stroke Scale (NIHSS), respectively. QoL was assessed using the Sarcopenia and Quality of Life questionnaire (SarQoL).ResultsThe prevalence of sarcopenia among stroke inpatients was 50.8%. Binary logistic regression analysis showed that age, limb dysfunction, dysphagia status, BI score, and NRS-2002 score were independently associated with sarcopenia, whereas regular exercise was associated with lower odds of sarcopenia. The total SarQoL score was 57.06 ± 17.583 in patients with sarcopenia and 66.72 ± 19.201 in patients without sarcopenia. Significant differences were observed between patients with and without sarcopenia in physical and mental health, locomotion, body composition, functionality, ADLs, fears, and the total SarQoL score.ConclusionThis study demonstrated a high prevalence of sarcopenia among stroke inpatients and identified several factors independently associated with sarcopenia. Sarcopenia was also associated with poorer sarcopenia-specific QoL.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12883-026-05066-2. Introduction Stroke is a leading cause of death and long-term disability worldwide [1]. In China, approximately 17.8 million people are living with stroke [2], representing a substantial national disease burden [3], which is expected to continue increasing and remain a major public health challenge [4]. Poststroke structural damage [5], difficulty swallowing or dysphagia [6], malnutrition [7], muscle wasting [8], hemiparesis [9], and inflammation [10] can impair physical function and lead to rapid decreases in muscle mass and structural muscle changes, resulting in sarcopenia [11, 12], which is generally considered a form of secondary sarcopenia and is referred to as stroke-related sarcopenia [13–15]. Compared with primary sarcopenia [11, 12], stroke-related sarcopenia is characterized by rapid adaptive changes in muscle structure occurring as early as 4 h after stroke [14, 15]; slow muscle fibres transform into fast muscle fibres and undergo increased proteolysis [16]. Stroke survivors with hemiplegia have 24% less muscle volume and 5% more subcutaneous fat volume in the affected thigh than in the unaffected thigh [17]. These features may further accelerate the development and progression of sarcopenia in stroke patients. Furthermore, stroke-related sarcopenia, reflecting the combined burden of stroke and sarcopenia, is associated with poorer quality of life (QoL), higher hospitalization and mortality rates, and increased healthcare burdens [13]. To promote healthy ageing, China formulated the “14th Five-Year Plan for Healthy Ageing” and explicitly noted that active protection and intervention measures should be taken against cerebrovascular diseases and sarcopenia (http://www.nhc.gov.cn/). Currently, several studies have examined stroke and sarcopenia, but stroke-related sarcopenia has not yet received sufficient attention [13]. Related research and clinical practice are still at an early stage, and few studies have reported its prevalence and associated factors. Moreover, because of differences in geographical location, cultural background, and diagnostic criteria across regions, the reported prevalence and associated factors of stroke-related sarcopenia vary among studies. Therefore, further research is needed to investigate the prevalence of stroke-related sarcopenia and the factors associated with it in different populations. A previous study suggested that stroke-related sarcopenia may be associated with poorer QoL in stroke survivors [13]. QoL is an important patient-reported outcome measure that helps clinicians and researchers understand patient perspectives and subjective experiences [18]. However, the Sarcopenia and Quality of Life questionnaire (SarQoL) [19], a tool specifically designed to assess sarcopenia-specific QoL, has not yet been applied to stroke inpatients. Therefore, it is necessary to assess QoL in patients with stroke-related sarcopenia and examine this association. Aims A cross-sectional survey was conducted to (a) estimate the prevalence of sarcopenia among stroke inpatients aged ≥ 18 years, (b) identify factors associated with stroke-related sarcopenia, and (c) examine the association between stroke-related sarcopenia and sarcopenia-specific QoL. Methods Ethical statement and participants This cross-sectional study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of Guizhou Provincial People’s Hospital (approval No.: 2023-060). Written informed consent was obtained from all participants prior to enrollment. Eligible inpatients with a clinical diagnosis of stroke [20] were consecutively recruited from the Departments of Neurology, Neurosurgery, Rehabilitation, Traditional Chinese Medicine, and Geriatrics at a tertiary Grade A comprehensive hospital in China. A total of 248 stroke inpatients were included. Patients were excluded if they had severe heart, liver, or kidney dysfunction or other serious diseases; were in a critical condition; had complete loss of autonomous activity; had oedema or conditions associated with altered hydration status; had severe limb disorders precluding the required assessments; had disturbance of consciousness; or had pacemaker implantation. Participants with oedema/altered hydration status and those with pacemaker implantation were excluded because bioelectrical impedance analysis (BIA)–based body composition estimates are influenced by fluid distribution/hydration, and BIA is generally not recommended in individuals with implanted electronic devices. The participant recruitment and selection process is shown in Fig. 1. Fig. 1Flowchart of participant recruitment and selection Flowchart of participant recruitment and selection Data collection Demographic and clinical characteristics Demographic and clinical information was collected for each participant, including age, sex, lifestyle factors, stroke-related characteristics, and C-reactive protein (CRP) levels. Regular exercise was defined as engaging in moderate-intensity exercise more than three times per week for more than 30 min each session, or achieving a total of at least 150 min of moderate-intensity or 75 min of vigorous-intensity physical activity per week [21]. Nutritional status, dysphagia, activities of daily living (ADLs), and stroke severity Nutritional status was assessed using Nutritional Risk Screening 2002 (NRS-2002) [22], where a total score ≥ 3 indicates nutritional risk. Swallowing function was evaluated using the water swallow test (WST) [23], and a score of 3–5 was considered dysphagia. ADLs were assessed using the Barthel Index (BI) [24], with lower scores indicating poorer independence. Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS) [25], with higher scores indicating more severe neurological deficits. Diagnosis of sarcopenia Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria [11]. Case finding was performed using calf circumference (CC) (men < 34 cm, women < 33 cm) and SARC-F (a five‑item questionnaire assessing Strength, Assistance walking, Rise from a chair, Climb stairs, and Falls) ≥ 4. Appendicular skeletal muscle mass (ASM) was measured using BIA (InBody S10, InBody Co., Ltd., Seoul, Republic of Korea). Low muscle mass was defined as ASM/height² < 7.0 kg/m² in men and < 5.7 kg/m² in women. Muscle strength was assessed using handgrip strength (HGS) (Xiangshan electronic hand dynamometer; Guangdong, China) in the non-paralyzed hand. In patients with stroke, the paretic hand may be substantially affected by neurological deficits and may be unable to perform a reliable standard handgrip strength test. Therefore, handgrip strength was measured in the non-paralyzed hand as a feasible approach for strength assessment in this inpatient population. Low muscle strength was defined as HGS < 28.0 kg for men and < 18.0 kg for women. Physical performance was assessed using the five-repetition sit-to-stand test (5STS), with ≥ 12 s indicating low physical performance. Assessment of QoL QoL was assessed using the Sarcopenia and Quality of Life questionnaire (SarQoL) [19]. The validated Chinese (Mandarin) version was used [26]. Scoring followed the developer’s instructions, with total and domain scores ranging from 0 to 100 and higher scores indicating better sarcopenia-specific QoL. The SarQoL is available free of charge for non-commercial academic use (sarqol.org). Sample size calculation According to the sample size estimation method for multivariate analysis in Clinical Epidemiology (edited by Wang) [27], the sample size should be at least 5–10 times the number of variables. In this study, 30 variables were considered; accounting for nonresponse, the sample size was increased by 10%. Thus, the minimum sample size was (30 × 5) × (1 + 10%) = 165 and the maximum sample size was (30 × 10) × (1 + 10%) = 330. The average of the minimum and maximum values was 247.5, which was rounded to 248 as the target sample size. Statistical analysis All statistical analyses were performed using SPSS version 24.0 (IBM Corp., Armonk, NY, USA). Continuous variables are presented as mean±standard deviation (SD), and categorical variables are presented as numbers (percentages). Between-group comparisons for continuous variables were performed using the independent-samples t test; when variances were unequal, Welch’s t test was used. Categorical variables were compared using the chi-square test. Fisher’s exact test was applied when more than 20% of the cells in an R × C contingency table had expected frequencies < 5 or when any expected frequency was < 1. To identify factors associated with sarcopenia, multivariable binary logistic regression was performed with sarcopenia status (yes = 1, no = 0) as the dependent variable. Candidate variables were initially identified based on prior literature and clinical relevance, and variables showing between-group differences in univariable analyses were subsequently entered into the multivariable logistic regression model. The variables entered in the model were age, regular exercise, limb dysfunction, complications, dysphagia status, BI score, NRS-2002 score, BMI, and NIHSS score. Model fit was evaluated using the Omnibus test of model coefficients and the Hosmer–Lemeshow goodness-of-fit test. To examine whether sarcopenia was independently associated with sarcopenia-specific QoL, multivariable linear regression was performed with the total SarQoL score as the dependent variable and sarcopenia status (yes = 1, no = 0) as the main independent variable. In the primary adjusted model, adjustment was made for age, sex, NIHSS score, NRS-2002 score, and dysphagia status. In a sensitivity analysis, additional adjustment was made for the BI score to account for ADLs. Multicollinearity was assessed using variance inflation factors (VIFs), and no substantial multicollinearity was detected (all VIFs ≤ 1.731). A two-sided P value < 0.05 was considered statistically significant. Results Participant characteristics and prevalence of sarcopenia A total of 248 stroke inpatients were included in the analysis, of whom 126 were classified as having sarcopenia according to the AWGS 2019 criteria, yielding a prevalence of 50.8%. As shown in Table 1, significant between-group differences were observed for age, regular exercise, limb dysfunction, complications, dysphagia status, BI score, NRS-2002 score, BMI, and NIHSS score (all P < 0.05). No significant between-group differences were observed for the remaining variables shown in Table 1 (all P > 0.05). Sarcopenia-related assessment variables are presented in Supplementary Table S1. Table 1Baseline demographic and clinical characteristics of stroke inpatients with and without sarcopenia (n = 248)VariableWithout sarcopenia(n = 122)With sarcopenia(n = 126)χ2/ tP valueDemographic characteristics Age, years59.98 ± 11.01166.63 ± 13.882-4.182b0.000 Sex, nmale70790.732a0.392female5247 Education level, nilliterate or semiliterate16199.348a0.155primary school3024junior high school3928high school414special secondary913junior college1114university1314 Residence, ncity or town74903.212a0.073countryside4836 Occupation type, nphysical work15170.240a0.887mental work5250other5559 Average monthly income, n≤ 1000 yuan25270.037a0.9821001–3000 yuan69703001–5000 yuan2829Lifestyle and stroke-related characteristics Smoking status, nno66812.665a0.103yes5645 Alcohol consumption, nno74851.247a0.264yes4841 Regular exercise, nno4410149.627a0.000yes7825 Health care products, nno86870.061a0.804yes3639 Stroke frequency, n1 time87981.523a0.4672 times33273 times21 Limb dysfunction, nno1054762.125a0.000yes1779 Admission form, nwalking50365.623a0.131assisted walking1817wheelchair2944stretcher2529 Admission type, noutpatient53560.025a0.874emergency6970 Lesion location, nleft47373.461a0.177right4156bilateral3433 Complications, nno401121.959a0.000yes82115 Admission diagnosis, ncerebral infarction49560.465a0.495cerebral haemorrhage7370 Duration of illness, n<1 month76653.582a0.3101–3 months7113–6 months436–12 months3547 Dysphagia status, nno995537.027a0.000yes2371Hospital stay, days7.16 ± 4.2557.51 ± 4.664-0.606b0.545Clinical, nutritional, and functional characteristics BI score73.85 ± 13.41952.26 ± 19.21010.287b0.000 NRS-2002 score2.91 ± 0.9273.99 ± 1.472-6.949b0.000 BMI, kg/m224.67 ± 3.14023.02 ± 3.3423.986b0.000 NIHSS score2.32 ± 1.6533.33 ± 2.180-4.135b0.000 CRP, mg/L6.24 ± 7.7926.89 ± 9.694-0.581b0.562Values are presented as mean ± SD or n (%). a: Chi-square test (χ2); b: Independent-samples t test (t) Table 1Baseline demographic and clinical characteristics of stroke inpatients with and without sarcopenia (n = 248)VariableWithout sarcopenia(n = 122)With sarcopenia(n = 126)χ2/ tP valueDemographic characteristics Age, years59.98 ± 11.01166.63 ± 13.882-4.182b0.000 Sex, nmale70790.732a0.392female5247 Education level, nilliterate or semiliterate16199.348a0.155primary school3024junior high school3928high school414special secondary913junior college1114university1314 Residence, ncity or town74903.212a0.073countryside4836 Occupation type, nphysical work15170.240a0.887mental work5250other5559 Average monthly income, n≤ 1000 yuan25270.037a0.9821001–3000 yuan69703001–5000 yuan2829Lifestyle and stroke-related characteristics Smoking status, nno66812.665a0.103yes5645 Alcohol consumption, nno74851.247a0.264yes4841 Regular exercise, nno4410149.627a0.000yes7825 Health care products, nno86870.061a0.804yes3639 Stroke frequency, n1 time87981.523a0.4672 times33273 times21 Limb dysfunction, nno1054762.125a0.000yes1779 Admission form, nwalking50365.623a0.131assisted walking1817wheelchair2944stretcher2529 Admission type, noutpatient53560.025a0.874emergency6970 Lesion location, nleft47373.461a0.177right4156bilateral3433 Complications, nno401121.959a0.000yes82115 Admission diagnosis, ncerebral infarction49560.465a0.495cerebral haemorrhage7370 Duration of illness, n<1 month76653.582a0.3101–3 months7113–6 months436–12 months3547 Dysphagia status, nno995537.027a0.000yes2371Hospital stay, days7.16 ± 4.2557.51 ± 4.664-0.606b0.545Clinical, nutritional, and functional characteristics BI score73.85 ± 13.41952.26 ± 19.21010.287b0.000 NRS-2002 score2.91 ± 0.9273.99 ± 1.472-6.949b0.000 BMI, kg/m224.67 ± 3.14023.02 ± 3.3423.986b0.000 NIHSS score2.32 ± 1.6533.33 ± 2.180-4.135b0.000 CRP, mg/L6.24 ± 7.7926.89 ± 9.694-0.581b0.562Values are presented as mean ± SD or n (%). a: Chi-square test (χ2); b: Independent-samples t test (t) Baseline demographic and clinical characteristics of stroke inpatients with and without sarcopenia (n = 248) Values are presented as mean ± SD or n (%). a: Chi-square test (χ2); b: Independent-samples t test (t) Factors associated with sarcopenia The overall logistic regression model was statistically significant (Omnibus χ² = 180.798, P < 0.001) and showed acceptable goodness of fit (Hosmer–Lemeshow test, P = 0.163) (Table 2). As shown in Table 3, multivariable binary logistic regression demonstrated that older age was associated with higher odds of sarcopenia (OR 1.064, 95% CI 1.024–1.105, P = 0.001), corresponding to an approximately 6.4% increase in the odds of sarcopenia per year of age. Regular exercise was associated with substantially lower odds of sarcopenia (OR 0.222, 95% CI 0.093–0.531, P = 0.001). Limb dysfunction showed a strong association with sarcopenia (OR 6.928, 95% CI 2.882–16.651, P < 0.001), and dysphagia status was also independently associated with sarcopenia (OR 2.856, 95% CI 1.236–6.601, P = 0.014). In addition, lower BI score (OR 0.949, 95% CI 0.925–0.974, P < 0.001) and higher NRS-2002 score (OR 1.472, 95% CI 1.016–2.132, P = 0.041) were independently associated with sarcopenia; each one-point increase in BI score was associated with approximately 5.1% lower odds of sarcopenia, whereas each one-point increase in NRS-2002 score was associated with approximately 47.2% higher odds of sarcopenia. Table 2Model fit statistics for the multivariable logistic regression modelOmnibus Tests of Model CoefficientsHosmer–Lemeshow TestChi-squaredfSig.stepChi-squaredfSig.step 1step180.79890.000111.74780.163block180.79890.000model180.79890.000 Table 2Model fit statistics for the multivariable logistic regression modelOmnibus Tests of Model CoefficientsHosmer–Lemeshow TestChi-squaredfSig.stepChi-squaredfSig.step 1step180.79890.000111.74780.163block180.79890.000model180.79890.000 Model fit statistics for the multivariable logistic regression model Table 3Multivariable binary logistic regression analysis of factors associated with sarcopeniaBS.E.WalddfSig.Exp(B)95% C.I. for EXP(B)LowerUpperStep 1aAge0.0620.01910.15010.0011.0641.0241.105Regular exercise-1.5060.44511.42210.0010.2220.0930.531Limb dysfunction1.9360.44718.71510.0006.9282.88216.651Complications0.6060.5631.15810.2821.8330.6085.526Dysphagia status1.0490.4276.02610.0142.8561.2366.601BI score-0.0520.01315.61510.0000.9490.9250.974NRS-2002 score0.3870.1894.18710.0411.4721.0162.132BMI-0.0700.0641.19310.2750.9330.8231.057NIHSS score0.1230.1231.00310.3171.1310.8891.438Constant-1.3612.2100.37910.5380.256a. The variables entered in step 1 were age, regular exercise, limb dysfunction, complications, dysphagia status, BI score, NRS-2002 score, BMI, and NIHSS score Table 3Multivariable binary logistic regression analysis of factors associated with sarcopeniaBS.E.WalddfSig.Exp(B)95% C.I. for EXP(B)LowerUpperStep 1aAge0.0620.01910.15010.0011.0641.0241.105Regular exercise-1.5060.44511.42210.0010.2220.0930.531Limb dysfunction1.9360.44718.71510.0006.9282.88216.651Complications0.6060.5631.15810.2821.8330.6085.526Dysphagia status1.0490.4276.02610.0142.8561.2366.601BI score-0.0520.01315.61510.0000.9490.9250.974NRS-2002 score0.3870.1894.18710.0411.4721.0162.132BMI-0.0700.0641.19310.2750.9330.8231.057NIHSS score0.1230.1231.00310.3171.1310.8891.438Constant-1.3612.2100.37910.5380.256a. The variables entered in step 1 were age, regular exercise, limb dysfunction, complications, dysphagia status, BI score, NRS-2002 score, BMI, and NIHSS score Multivariable binary logistic regression analysis of factors associated with sarcopenia a. The variables entered in step 1 were age, regular exercise, limb dysfunction, complications, dysphagia status, BI score, NRS-2002 score, BMI, and NIHSS score Sarcopenia-specific QoL The total SarQoL score was lower in patients with sarcopenia (57.06 ± 17.583) than in those without sarcopenia (66.72 ± 19.201). As shown in Table 4, significant between-group differences were observed in physical and mental health, locomotion, body composition, functionality, ADLs, fears, and the total SarQoL score (all P < 0.05). No significant between-group difference was found for leisure activities (P = 0.095). Table 4Comparison of SarQoL scores between stroke inpatients with and without sarcopeniaVariableWithout sarcopenia(n = 122)With sarcopenia(n = 126)tP valuePhysical and mental health67.72 ± 18.63758.79 ± 18.1503.8230.000Locomotion59.40 ± 24.09146.75 ± 21.5554.3540.000Body composition73.51 ± 17.57267.81 ± 17.4302.5650.011Functionality76.87 ± 18.32568.01 ± 17.5753.8900.000ADLs63.94 ± 22.21253.19 ± 20.0754.0020.000Leisure activities36.47 ± 12.21634.31 ± 7.3421.6800.095Fears64.88 ± 21.92258.43 ± 17.7842.5400.012Total SarQoL score66.72 ± 19.20157.06 ± 17.5834.1340.000Values are presented as mean ± SD. Independent-samples t test (t) was used for between-group comparisons Table 4Comparison of SarQoL scores between stroke inpatients with and without sarcopeniaVariableWithout sarcopenia(n = 122)With sarcopenia(n = 126)tP valuePhysical and mental health67.72 ± 18.63758.79 ± 18.1503.8230.000Locomotion59.40 ± 24.09146.75 ± 21.5554.3540.000Body composition73.51 ± 17.57267.81 ± 17.4302.5650.011Functionality76.87 ± 18.32568.01 ± 17.5753.8900.000ADLs63.94 ± 22.21253.19 ± 20.0754.0020.000Leisure activities36.47 ± 12.21634.31 ± 7.3421.6800.095Fears64.88 ± 21.92258.43 ± 17.7842.5400.012Total SarQoL score66.72 ± 19.20157.06 ± 17.5834.1340.000Values are presented as mean ± SD. Independent-samples t test (t) was used for between-group comparisons Comparison of SarQoL scores between stroke inpatients with and without sarcopenia Values are presented as mean ± SD. Independent-samples t test (t) was used for between-group comparisons Given the between-group differences in clinical characteristics, additional adjusted analyses were performed. After adjustment for age, sex, NIHSS score, NRS-2002 score, and dysphagia status, sarcopenia was independently associated with a lower total SarQoL score (β = −6.612, 95% CI − 12.078 to − 1.146, P = 0.018). This finding suggests that, after accounting for relevant demographic and clinical factors, patients with sarcopenia had worse sarcopenia-specific QoL than those without sarcopenia. In a sensitivity analysis with additional adjustment for the BI score, the association was attenuated and was no longer statistically significant (β = −3.455, 95% CI − 9.346 to 2.435, P = 0.249), suggesting that ADLs may partly account for the association between sarcopenia and sarcopenia-specific QoL. Discussion Stroke and sarcopenia may co-occur and be mutually reinforcing, which can adversely affect functional outcomes and QoL. Therefore, this cross-sectional study was conducted to estimate the prevalence of sarcopenia among stroke inpatients, identify factors associated with sarcopenia, and examine the association between sarcopenia and sarcopenia-specific QoL. This study identified three important clinical findings. First, approximately half of the stroke inpatients had sarcopenia. Second, older age, limb dysfunction, dysphagia status, lower BI score, and higher NRS-2002 score were independently associated with sarcopenia, whereas regular exercise was associated with lower odds of sarcopenia. Third, patients with sarcopenia had poorer sarcopenia-specific QoL. The high prevalence of stroke-related sarcopenia has been supported by the findings of previous studies. The highest, lowest and pooled prevalence of stroke-related sarcopenia were 16.8%, 60.3%, and 42%, respectively [28]. However, the prevalence of primary sarcopenia ranges between 10% and 27% [29]. Moreover, compared to other common chronic diseases, sarcopenia appears to be more prevalent among stroke patients than among patients with several other chronic conditions. For example, the pooled prevalence of sarcopenia in patients with diabetes was 18% [30], that of sarcopenia in patients with rheumatological pathology was 31.2% [31], and that of sarcopenia in patients with cancer was 33% [32]. The prevalence reached 50.8% in this study, further confirming the high prevalence of stroke-related sarcopenia. Thus, early identification and timely intervention are essential. In particular, routine screening and early identification of stroke-related sarcopenia in inpatient settings may be warranted, together with timely multidisciplinary interventions. A previous study [8] indicated that sarcopenia was related to time since stroke; the prevalence of sarcopenia was higher after 1 month, and spasticity and walking ability might be associated with lower odds of sarcopenia. Other studies [33, 34] have reported that stroke severity, physical activity, complications, nutritional status, and cognitive impairment may be associated with stroke-related sarcopenia. In the present study, older age, limb dysfunction, dysphagia status, lower BI score, and higher NRS-2002 score were independently associated with sarcopenia, whereas regular exercise was associated with lower odds of sarcopenia. The results indicated that older age was associated with a higher likelihood of sarcopenia. Although some studies have shown that stroke-related sarcopenia is unrelated to age [8, 15], the causes of sarcopenia, such as age, lack of activity, malnutrition, and disease, may overlap in older patients with stroke, as indicated by other studies [35, 36]. Therefore, the association between age and stroke-related sarcopenia should not be overlooked, and additional attention should be given to older stroke patients. Limb dysfunction was strongly associated with sarcopenia and is a common deficit after stroke. Nearly three-quarters of stroke patients experience limb dysfunction [37], which can reduce their ability to perform ADLs. Therefore, personalized early intervention and management strategies are needed to promote recovery. Stroke and sarcopenia are both important contributors to ADLs limitations, and the BI is a widely used tool for assessing independence in daily living [38, 39]. In this study, BI scores were significantly lower in patients with sarcopenia than in those without sarcopenia, suggesting that poorer ADLs performance may help identify stroke patients at higher likelihood of sarcopenia. Particular attention should therefore be given to stroke patients with low BI scores. In this study, dysphagia (based on the WST) was independently associated with sarcopenia. It was reported that the prevalence of dysphagia after stroke reaches 80%, which is related to adverse outcomes, length of stay and hospitalization expenses [6], and dysphagia is often associated with higher nutritional risk [40]. In addition, the association between the NRS-2002 score and sarcopenia prevalence indicated that nutritional risk was also independently associated with sarcopenia in the study population. Therefore, accurate identification of dysphagia and early assessment of nutritional status are essential, in addition to targeted measures to improve swallowing function and patient-specific nutritional support. Regular exercise was associated with lower odds of sarcopenia in stroke patients in this study. Exercise has well-established benefits and has been associated with lower stroke risk [41], lower risk of sarcopenia [42], and better physical function [43]. However, stroke inpatients and survivors often lack access to structured, individualized exercise guidance regarding appropriate type, intensity, and frequency. Future research should develop and evaluate feasible, tailored exercise prescriptions and behavioral support strategies for stroke populations, especially those at risk of sarcopenia. With the shift in the healthcare model, the patient perspective is now widely recognized as an important component of health evaluation [18]. Clinical assessment is no longer limited to changes in symptoms, imaging findings, or laboratory indices [26, 44], and QoL has also become an important outcome. In the present study, the total SarQoL score was lower in stroke inpatients with sarcopenia than in those without sarcopenia (57.06 ± 17.583 vs. 66.72 ± 19.201). Moreover, significant differences were observed in physical and mental health, locomotion, body composition, functionality, ADLs, and fears, suggesting that stroke-related sarcopenia was associated with poorer QoL across multiple domains. These findings underscore the importance of early, targeted multidisciplinary interventions to address sarcopenia-related impairments and potentially improve sarcopenia-specific QoL in stroke inpatients. This study provides additional evidence on the prevalence of sarcopenia and factors associated with sarcopenia among stroke inpatients. It also provides early evidence on sarcopenia-specific QoL in this population, which may inform future research and clinical practice. Clinical implications From a rehabilitation perspective, these findings support incorporating sarcopenia screening into routine inpatient stroke care. A practical pathway may start with case finding using calf circumference and SARC-F, followed by confirmation with handgrip strength and 5STS, and, when feasible, measurement of muscle mass. Because sarcopenia was associated with dysphagia, nutritional risk, and poorer ADLs performance, early multidisciplinary management should prioritize nutrition risk screening and individualized nutritional support, dysphagia assessment and swallowing interventions, and progressive mobilization/strength training during hospitalization. In addition, structured patient education (e.g., nutrition and home exercise guidance), goal setting, and follow-up planning after discharge may strengthen self-management and improve adherence. Such targeted measures may help mitigate disability and improve sarcopenia-specific QoL in stroke inpatients. Implications for rehabilitation Stroke inpatients show a high prevalence of sarcopenia; routine inpatient screening may be warranted.Dysphagia, nutritional risk, and poorer ADLs performance are closely linked to sarcopenia, supporting early multidisciplinary management.Patient education and discharge planning may enhance self-management and potentially improve sarcopenia-specific QoL. Stroke inpatients show a high prevalence of sarcopenia; routine inpatient screening may be warranted. Stroke inpatients show a high prevalence of sarcopenia; routine inpatient screening may be warranted. Dysphagia, nutritional risk, and poorer ADLs performance are closely linked to sarcopenia, supporting early multidisciplinary management. Dysphagia, nutritional risk, and poorer ADLs performance are closely linked to sarcopenia, supporting early multidisciplinary management. Patient education and discharge planning may enhance self-management and potentially improve sarcopenia-specific QoL. Patient education and discharge planning may enhance self-management and potentially improve sarcopenia-specific QoL. Limitations This study has several limitations. First, the cross-sectional design precludes conclusions about temporal relationships or causality between stroke-related factors, sarcopenia, and QoL. Second, patients with severe disability or impaired consciousness were excluded because they could not complete sarcopenia-related assessments; therefore, selection bias may limit the generalizability of the prevalence estimates to all inpatient stroke populations. Third, although adjusted analyses were performed for SarQoL outcomes, residual confounding cannot be fully excluded. In addition, handgrip strength was assessed using the non-paralyzed hand. Although this approach was adopted for feasibility in stroke inpatients, it may not fully reflect overall muscle strength and may have led to some misclassification of sarcopenia status. Furthermore, although patients with oedema or obvious altered hydration status were excluded, BIA-derived muscle mass estimates may still have been influenced by hydration fluctuations and clinical status in hospitalized stroke patients, which could have introduced measurement bias. Future multicenter longitudinal studies and intervention trials are warranted to clarify temporal relationships and to evaluate whether targeted interventions for sarcopenia improve post-stroke outcomes. Conclusion In summary, this study examined the prevalence of sarcopenia and factors associated with sarcopenia among stroke inpatients. This study is among the first to evaluate sarcopenia-specific QoL in this population using the SarQoL. The prevalence of sarcopenia among stroke inpatients was 50.8%. Age, limb dysfunction, dysphagia status, BI score, and NRS-2002 score were independently associated with sarcopenia, whereas regular exercise was associated with lower odds of sarcopenia. Sarcopenia was also associated with poorer sarcopenia-specific QoL. These findings highlight the need for early identification and targeted management of sarcopenia during inpatient stroke care. Supplementary Information Supplementary Material 1. Supplementary Material 1.